Tag: Breast Cancer

July 18, 2017 Off

FDA OK’s Puma Biotechnology’s cancer drug

By Dino Mustafić

The U.S. Food and Drug Administration has approved Puma Biotechnology’s neratinib for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.

May 18, 2017 Off

Oxford BioDynamics subsidiary signs exclusive Asia licence for breast cancer test

By Dino Mustafić

Oxford BioDynamics’s subsidiary Oxford BioDynamics Pte Limited, has signed an exclusive licence agreement with Nova Satra Diagnostics Asia Limited, to supply its proprietary products and reagents for the potential use in a non-invasive blood test to assist in the diagnosis of breast cancer, in complementation to current breast cancer screening procedures, across 13 territories in Asia.